A comprehensive view of Cardiovascular / Heart Health. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.
Novo Nordisk's acquisition of Cardior Pharmaceuticals gets approval from Germany's Federal Cartel Office; Novo Nordisk to buy the company for US$1.09B, which is expected to expand its pipeline of heart drugs
Published:
April 18, 2024
by SeeNews Deals
|
FDA grants fast track designation to Asklepios BioPharmaceutical's AB-1002, a gene therapy for adults with non-ischemic cardiomyopathy and Class III heart failure symptoms; the therapy is currently in Phase 2 trials
Published:
April 18, 2024
by Bayer AG
|
Executive Perspective: J&J to continue its aggressive medtech M&A strategy after spending US$30.0B in less than two years, says CEO; recent acquisitions include Shockwave Medical, Abiomed, Laminar, and Ambrx, as the company targets long-term growth
Published:
April 17, 2024
by FierceBiotech
|
Patent Application Titled 'Treatment Of Vasculopathy With Prostacyclin And Mesenchymal Stem Cells' Published Online (USPTO 20240100003)
Published:
April 17, 2024
by Heart Disease Daily
|
FDA issues recall of over 13,000 Thoratec Corp. HeartMate II and HeartMate 3 heart pumps; the pumps are used in patients with end-stage heart failure
Published:
April 16, 2024
by Kaiser Health News
|
Ask us about our Health Care Sector market view